+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Expansion Market - Global Forecast 2026-2032- Product Image
Cell Expansion Market - Global Forecast 2026-2032- Product Image
Sale

Cell Expansion Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995206
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Expansion Market is projected to reach USD 23.18 Billion in 2026. It is expected to continue growing at a CAGR of 15.80%, reaching USD 56.86 Billion by 2032.

Cell expansion is a core enabling technology for biopharmaceutical manufacturing, regenerative medicine, cell and gene therapy, vaccine development, immuno-oncology, and translational research. The market is shaped by rising demand for scalable cell culture systems, serum-free and xeno-free media, single-use bioreactors, closed-system automation, and high-quality reagents that support reproducible cell growth, viability, potency, and contamination control.

Publicly observable demand signals remain strong: regulatory activity for cell and gene therapies continues to expand across FDA and EMA pathways, ClinicalTrials.gov lists thousands of active cell therapy-related studies globally, and biomanufacturing investment remains closely tied to advanced therapy medicinal products. As developers move from laboratory-scale workflows to clinical and commercial manufacturing, cell expansion solutions are increasingly evaluated on sterility assurance, process scalability, cost per dose, regulatory traceability, chain-of-identity control, and compatibility with good manufacturing practice standards.

Transformative Shifts in the Cell Expansion Landscape

The cell expansion landscape is shifting from open, manual, research-grade workflows toward closed, automated, digitally monitored, and GMP-aligned manufacturing ecosystems. This transition is especially important for autologous cell therapies, where patient-specific variability and short vein-to-vein timelines require robust process control, and for allogeneic approaches, where larger batch sizes demand scalable expansion platforms with consistent cell phenotype and potency.

Suppliers are differentiating through integrated portfolios that combine media, growth factors, cultureware, bioreactors, sensors, analytics, cell separation tools, and cryopreservation solutions. The industry is also moving toward serum-free, xeno-free, and chemically defined media to reduce variability and support regulatory acceptance. At the same time, capacity constraints, skilled labor shortages, cold-chain complexity, and quality-control requirements are accelerating adoption of modular manufacturing, single-use assemblies, automated cell processing systems, and standardized digital batch documentation.

Cumulative Impact of Artificial Intelligence on Cell Expansion

Artificial intelligence is becoming a practical accelerator for cell expansion by improving experimental design, process optimization, quality prediction, and manufacturing decision-making. AI and machine learning models can analyze high-dimensional data from cell counts, metabolite profiles, imaging, flow cytometry, bioreactor sensors, electronic batch records, and environmental monitoring systems to identify patterns that are difficult to detect through conventional statistical methods.

The strongest near-term impact is in predictive process control, anomaly detection, media optimization, donor variability assessment, and release testing support. AI-enabled image analysis can improve consistency in confluence assessment and morphology tracking, while digital twins can help manufacturers simulate scale-up scenarios before committing costly GMP resources. However, adoption depends on validated data integrity, explainable models, cybersecurity, audit-ready documentation, and alignment with regulatory expectations for computerized systems, model lifecycle management, and quality-by-design manufacturing.

Key Regional Insights for Cell Expansion

Asia-Pacific is gaining importance as China, Japan, South Korea, India, Singapore, and Australia expand regenerative medicine research, biologics manufacturing, and clinical trial activity. China has built substantial biopharma capacity and remains highly active in immune cell therapy research; Japan benefits from an established regenerative medicine regulatory framework; South Korea continues to invest in advanced biologics and cell therapy infrastructure; India is strengthening cost-efficient biomanufacturing capabilities; and Australia supports early-phase clinical translation through strong hospital and research networks.

North America remains a leading hub because of the concentration of FDA-regulated clinical development, venture funding, academic medical centers, contract development and manufacturing organizations, and commercial cell therapy launches in the United States, with Canada contributing recognized stem cell science, translational research, and biomanufacturing initiatives. Latin America is developing gradually, led by Brazil and Mexico, where public health demand, clinical research networks, improving biologics capacity, and university-led biomedical programs support future adoption of cell expansion technologies.

Europe benefits from EMA oversight, advanced therapy medicinal product expertise, and strong clusters in Germany, France, the United Kingdom, Italy, Spain, the Netherlands, Belgium, Switzerland, and the Nordics. The Middle East is investing in biomedical innovation, precision medicine, specialty hospitals, genomics, and local production ambitions, particularly in the Gulf. Africa is earlier-stage but strategically relevant as vaccine manufacturing programs, academic partnerships, regional bioprocessing initiatives, and public health-focused biotechnology capacity build the foundation for long-term cell culture and cell expansion adoption.

Key Group Insights for Cell Expansion

ASEAN is emerging as a manufacturing and clinical research corridor, supported by Singapore's bioprocessing ecosystem, Thailand's medical innovation programs, Malaysia's life sciences base, Vietnam's expanding healthcare investment, and Indonesia's healthcare scale. These dynamics make the region increasingly relevant for cell culture consumables, bioprocess training, translational research, and future cell therapy manufacturing readiness. The GCC is investing in advanced healthcare infrastructure, genomics, precision medicine, specialty care, and local biomanufacturing ambitions, making cell expansion relevant to long-term national strategies focused on healthcare diversification and advanced therapeutics access.

The European Union provides a harmonized regulatory environment for advanced therapy medicinal products, while national centers of excellence support process development, quality systems, and GMP translation. BRICS countries represent a significant demand base because of large patient populations, expanding biologics manufacturing, academic research activity, and public-sector interest in local production. G7 markets continue to lead in funding intensity, regulatory maturity, intellectual property generation, clinical trial infrastructure, and commercial adoption of advanced therapies. NATO countries overlap heavily with mature biopharma economies, where supply chain resilience, sterile manufacturing, critical reagent access, and domestic bioproduction capacity are increasingly strategic priorities.

Key Country Insights for Cell Expansion

The United States leads global cell expansion demand through its concentration of FDA-regulated cell and gene therapy pipelines, academic medical centers, biotech funding, GMP manufacturing sites, and contract development and manufacturing capacity. Canada contributes recognized stem cell science, translational research, and supportive public-private biomanufacturing initiatives. Mexico and Brazil are building relevance through clinical research, biologics demand, regional healthcare modernization, and growing interest in local biomanufacturing capabilities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced clinical research, hospital networks, regulatory experience, and GMP manufacturing expertise, while Russia maintains scientific capacity but faces constraints linked to sanctions, technology access, supply chain limitations, and capital flows. China is one of the most active countries in cell therapy clinical development and manufacturing scale-up. India is advancing through cost-efficient biomanufacturing, stem cell research, vaccine and biologics expertise, and a growing biotech base. Japan benefits from regenerative medicine policy experience and strong translational research; Australia offers robust clinical trial infrastructure and biomedical research quality; and South Korea is a leading Asian hub for biologics, biosimilars, regenerative medicine, and cell therapy manufacturing.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize closed, automated, and scalable cell expansion platforms that reduce contamination risk, improve batch consistency, support GMP documentation, and enable stronger chain-of-identity and chain-of-custody control. Developers of cell therapies should select expansion technologies early in development to avoid costly process comparability challenges during scale-up, technology transfer, and regulatory submission.

Manufacturers should invest in serum-free, xeno-free, and chemically defined media; real-time analytics; validated digital systems; and quality-by-design frameworks to improve reproducibility and reduce cost of goods. Partnerships with contract manufacturers, academic medical centers, automation vendors, reagent suppliers, and analytics providers can shorten development timelines. Leaders should also build resilient supply chains for critical reagents, single-use components, cytokines, growth factors, cultureware, and consumables, while maintaining qualified dual sourcing where quality, continuity, and regulatory requirements allow.

Research Methodology

This executive summary is based on a structured market research methodology that triangulates public regulatory databases, clinical trial registries, peer-reviewed publications, government health data, trade information, patent activity, manufacturing announcements, and expert interpretation of bioprocessing trends. Key sources typically include FDA, EMA, WHO, ClinicalTrials.gov, national statistics agencies, recognized patent databases, public investor disclosures, and scientific literature indexed in established repositories.

The methodology evaluates demand drivers, technology adoption, manufacturing constraints, regulatory dynamics, regional capacity, supply chain resilience, and competitive positioning without relying on unsupported projections. Findings are validated through cross-source comparison to reduce dependence on single-point evidence. Market interpretation emphasizes verified developments, observable investment patterns, approved therapy trends, clinical pipeline activity, regulatory requirements, and practical manufacturing needs across research, clinical, and commercial cell expansion workflows.

Conclusion

The cell expansion market is transitioning from a research-support segment into a strategic manufacturing foundation for next-generation medicine. Growth is being driven by cell and gene therapy pipelines, regenerative medicine, biologics development, vaccine research, immuno-oncology, and the need for scalable, reproducible, and compliant cell culture processes.

Competitive advantage will increasingly depend on automation, closed processing, AI-enabled analytics, defined media systems, validated quality controls, and regional manufacturing resilience. Organizations that align technology selection with regulatory expectations, clinical scalability, sterility assurance, and cost-of-goods discipline will be best positioned to capture value as cell-based therapies move from specialized treatment centers toward broader commercial access.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell Expansion Market, by Product Type
7.1. Introduction
7.2. Cell Culture Media
7.2.1. Serum Based Media
7.2.2. Serum Free Media
7.3. Reagents
7.3.1. Buffers
7.3.2. Antibiotics
7.4. Bioreactors
7.4.1. Stirred Tank Bioreactors
7.4.2. Wave Bioreactors
7.4.3. Hollow Fiber Bioreactors
7.5. Cell Counters
7.6. Culture Vessels
8. Cell Expansion Market, by Technology
8.1. Introduction
8.2. 2D Cell Culture
8.3. 3D Cell Culture
8.3.1. Spheroid
8.3.2. Organoid
8.4. Scaffold based Culture
8.4.1. Hydrogel
8.4.2. Polymer
8.5. Suspension Culture
8.6. Perfusion Systems
9. Cell Expansion Market, by Cell Type
9.1. Introduction
9.2. Mammalian Cells
9.2.1. CHO Cells
9.2.2. HEK Cells
9.3. Stem Cells
9.4. Immune Cells
9.4.1. T Cells
9.4.2. NK Cells
9.4.3. Dendritic Cells
9.5. Microbial Cells
9.5.1. Bacteria
9.5.2. Yeast
9.6. Primary Cells
9.6.1. Hepatocytes
9.6.2. Fibroblasts
9.6.3. Endothelial
10. Cell Expansion Market, by Culture System
10.1. Introduction
10.2. Open
10.3. Closed
10.4. Automated
11. Cell Expansion Market, by Application
11.1. Introduction
11.2. Biopharmaceutical Production
11.2.1. Monoclonal Antibody Production
11.2.2. Recombinant Protein Production
11.3. Cell & Gene Therapy
11.4. Regenerative Medicine
11.4.1. Tissue Engineering
11.4.2. Organ Regeneration Research
11.5. Research & Development
11.6. Toxicology Testing
12. Cell Expansion Market, by End User
12.1. Introduction
12.2. Academic Research Institutes
12.3. Biotechnology Companies
12.4. Contract Manufacturing Organizations
12.5. Pharmaceutical Companies
13. Cell Expansion Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Cell Expansion Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cell Expansion Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Agilent Technologies Inc
17.2. Allogene Therapeutics Inc
17.3. Becton Dickinson and Company
17.4. Bio-Techne Corporation
17.5. Cellectis SA
17.6. CellGenix GmbH
17.7. Corning Incorporated
17.8. Cytiva Uppsala AB
17.9. Danaher Corporation
17.10. Eppendorf SE
17.11. FUJIFILM Irvine Scientific Inc
17.12. GE HealthCare Technologies Inc
17.13. Getinge AB
17.14. HiMedia Laboratories Pvt Ltd
17.15. Kite Pharma Inc
17.16. Lonza Group AG
17.17. Merck KGaA
17.18. Miltenyi Biotec GmbH
17.19. PBS Biotech Inc
17.20. Promab Biotechnologies Inc
17.21. PromoCell GmbH
17.22. Repligen Corporation
17.23. Sartorius AG
17.24. STEMCELL Technologies Inc
17.25. Takara Bio Inc
17.26. Takara Bio USA Holdings Inc
17.27. Terumo Corporation
17.28. Thermo Fisher Scientific Inc
17.29. WuXi AppTec Co Ltd
List of Figures
FIGURE 1. GLOBAL CELL EXPANSION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CELL EXPANSION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CELL EXPANSION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CELL EXPANSION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CELL EXPANSION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CELL EXPANSION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CELL EXPANSION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CELL EXPANSION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL CELL EXPANSION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CELL EXPANSION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CELL EXPANSION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CELL CULTURE MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SERUM BASED MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SERUM BASED MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SERUM BASED MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SERUM FREE MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SERUM FREE MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SERUM FREE MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BUFFERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BUFFERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BUFFERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL BIOREACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL STIRRED TANK BIOREACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL STIRRED TANK BIOREACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL STIRRED TANK BIOREACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL HOLLOW FIBER BIOREACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HOLLOW FIBER BIOREACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HOLLOW FIBER BIOREACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CELL COUNTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CELL COUNTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CELL COUNTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CULTURE VESSELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CULTURE VESSELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CULTURE VESSELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL 2D CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL 2D CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL 2D CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL 3D CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SPHEROID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SPHEROID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SPHEROID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ORGANOID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ORGANOID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ORGANOID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SCAFFOLD BASED CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SCAFFOLD BASED CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SCAFFOLD BASED CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HYDROGEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HYDROGEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HYDROGEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL POLYMER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PERFUSION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PERFUSION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PERFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CHO CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CHO CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CHO CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HEK CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HEK CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HEK CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL STEM CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL IMMUNE CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL IMMUNE CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL IMMUNE CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL T CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL T CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL T CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL NK CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL NK CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL NK CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DENDRITIC CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DENDRITIC CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL DENDRITIC CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MICROBIAL CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MICROBIAL CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL MICROBIAL CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL BACTERIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL BACTERIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL BACTERIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL YEAST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL YEAST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL YEAST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PRIMARY CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL HEPATOCYTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL HEPATOCYTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HEPATOCYTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL FIBROBLASTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL FIBROBLASTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL FIBROBLASTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ENDOTHELIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ENDOTHELIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ENDOTHELIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL OPEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL OPEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL OPEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CLOSED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CLOSED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CLOSED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL BIOPHARMACEUTICAL PRODUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL BIOPHARMACEUTICAL PRODUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL BIOPHARMACEUTICAL PRODUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL ORGAN REGENERATION RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL ORGAN REGENERATION RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ORGAN REGENERATION RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 187. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 188. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 189. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 191. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 192. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 193. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 194. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 195. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 196. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 197. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 198. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 205. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 206. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 207. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 208. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 209. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 210. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 211. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 212. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 213. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 214. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 215. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. EUROPE CELL EXPANSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 221. EUROPE CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 222. EUROPE CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 223. EUROPE CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 224. EUROPE CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 225. EUROPE CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 226. EUROPE CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 227. EUROPE CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 228. EUROPE CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 229. EUROPE CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 230. EUROPE CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 231. EUROPE CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 232. EUROPE CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 233. EUROPE CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 234. EUROPE CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. EUROPE CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 236. EUROPE CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 237. EUROPE CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 239. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 245. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 246. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 247. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 248. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 249. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 250. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 251. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 252. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. AFRICA CELL EXPANSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 257. AFRICA CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. AFRICA CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 259. AFRICA CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 260. AFRICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 261. AFRICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 262. AFRICA CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 263. AFRICA CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 264. AFRICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 265. AFRICA CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 266. AFRICA CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 267. AFRICA CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 268. AFRICA CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 269. AFRICA CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 270. AFRICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. AFRICA CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 272. AFRICA CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 273. AFRICA CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. GLOBAL CELL EXPANSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 275. ASEAN CELL EXPANSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. ASEAN CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. ASEAN CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 278. ASEAN CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 279. ASEAN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 280. ASEAN CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 281. ASEAN CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 282. ASEAN CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 283. ASEAN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 284. ASEAN CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 285. ASEAN CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 286. ASEAN CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 287. ASEAN CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 288. ASEAN CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 289. ASEAN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 290. ASEAN CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 291. ASEAN CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 292. ASEAN CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. GCC CELL EXPANSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 294. GCC CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. GCC CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 296. GCC CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 297. GCC CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 298. GCC CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. GCC CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 300. GCC CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 301. GCC CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 302. GCC CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 303. GCC CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 304. GCC CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 305. GCC CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 306. GCC CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 307. GCC CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. GCC CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 309. GCC CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 310. GCC CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 317. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 318. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. BRICS CELL EXPANSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 330. BRICS CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 331. BRICS CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 332. BRICS CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 333. BRICS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 334. BRICS CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 335. BRICS CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 336. BRICS CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 337. BRICS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 338. BRICS CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 339. BRICS CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 340. BRICS CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 341. BRICS CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 342. BRICS CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 343. BRICS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 344. BRICS CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 345. BRICS CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 346. BRICS CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 347. G7 CELL EXPANSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 348. G7 CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 349. G7 CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 350. G7 CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 351. G7 CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 352. G7 CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 353. G7 CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 354. G7 CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 355. G7 CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 356. G7 CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 357. G7 CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 358. G7 CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 359. G7 CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 360. G7 CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE 361. G7 CELL EXPANSION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 362. G7 CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2017-2032 (USD MILLION)
TABLE 363. G7 CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2017-2032 (USD MILLION)
TABLE 364. G7 CELL EXPANSION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 365. NATO CELL EXPANSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 366. NATO CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 367. NATO CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2017-2032 (USD MILLION)
TABLE 368. NATO CELL EXPANSION MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 369. NATO CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2017-2032 (USD MILLION)
TABLE 370. NATO CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 371. NATO CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 372. NATO CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2017-2032 (USD MILLION)
TABLE 373. NATO CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 374. NATO CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2017-2032 (USD MILLION)
TABLE 375. NATO CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2017-2032 (USD MILLION)
TABLE 376. NATO CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2017-2032 (USD MILLION)
TABLE 377. NATO CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2017-2032 (USD MILLION)
TABLE 378. NATO CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2017-2032 (USD MILLION)
TABLE

Companies Mentioned

  • Agilent Technologies Inc
  • Allogene Therapeutics Inc
  • Becton Dickinson and Company
  • Bio-Techne Corporation
  • Cellectis SA
  • CellGenix GmbH
  • Corning Incorporated
  • Cytiva Uppsala AB
  • Danaher Corporation
  • Eppendorf SE
  • FUJIFILM Irvine Scientific Inc
  • GE HealthCare Technologies Inc
  • Getinge AB
  • HiMedia Laboratories Pvt Ltd
  • Kite Pharma Inc
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • PBS Biotech Inc
  • Promab Biotechnologies Inc
  • PromoCell GmbH
  • Repligen Corporation
  • Sartorius AG
  • STEMCELL Technologies Inc
  • Takara Bio Inc
  • Takara Bio USA Holdings Inc
  • Terumo Corporation
  • Thermo Fisher Scientific Inc
  • WuXi AppTec Co Ltd

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 23.18 Billion
Forecasted Market Value ( USD ) by 2032 $ 56.86 Billion
Compound Annual Growth Rate15.8%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Cell Expansion - Global Strategic Business Report - Product Image

Cell Expansion - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Serum-free T Cell Expansion Medium Market - Global Forecast 2026-2032 - Product Image

Serum-free T Cell Expansion Medium Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Cell Expansion Market Report 2026 - Product Image

Cell Expansion Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cell Expansion Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Cell Type, Application, End User - Product Image

Cell Expansion Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Cell Type, Application, End User

  • Report
  • 160 Pages
  • Global
From
Cell Expansion Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Cell Expansion Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 185 Pages
  • Global
From

About the Market

Cell Expansion is a biotechnology market that focuses on the development of technologies and products that enable the growth and expansion of cells. This includes the development of cell culture media, cell culture systems, and cell expansion systems. Cell expansion technologies are used in a variety of applications, such as drug discovery, cell therapy, and regenerative medicine. Cell expansion technologies are also used in research and development, as well as in the production of biopharmaceuticals. Cell expansion technologies are used to increase the number of cells in a culture, allowing for more efficient production of biopharmaceuticals. This technology also enables researchers to study the behavior of cells in different environments, as well as to develop new cell-based therapies. Cell expansion technologies are used in a variety of industries, including biotechnology, pharmaceuticals, and medical devices. Companies in this market include Thermo Fisher Scientific, Merck KGaA, Corning, Lonza, and Sartorius. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.